PP
CLBT icon

Pertento Partners’s Cellebrite CLBT Stock Holding History

Pertento Partners’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117M Buy
8,004,867
+1,342,213
+20% +$17.7M 6.3% 6
2026
Q1 		$91.8M Buy
6,662,654
+703,330
+12% +$10.6M 6.72% 5
2025
Q4 		$107M Buy
5,959,324
+1,311,109
+28% +$23.5M 10.09% 3
2025
Q3 		$86.1M Buy
4,648,215
+1,702,574
+58% +$26.7M 9.99% 3
2025
Q2 		$47.1M Buy
2,945,641
+309,988
+12% +$5.53M 4.22% 9
2025
Q1 		$51.2M Sell
2,635,653
-339,721
-11% -$7.15M 5.36% 8
2024
Q4 		$65.5M Buy
2,975,374
+626,373
+27% +$12.1M 5.55% 4
2024
Q3 		$39.6M Buy
+2,349,001
New +$34.9M 4.36% 12

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pertento Partners's CLBT Position: Q2 2026 in Review

Pertento Partners increased its Cellebrite (CLBT) stake by 20% in Q2 2026, buying an estimated $17.7M and bringing the position to 8,004,867 shares worth $117M. The position accounts for 6.3% of the portfolio, ranked #6.

Pertento Partners first reported a position in CLBT in Q3 2024 and has held it in 8 quarters since. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Pertento Partners held 8,004,867 shares of Cellebrite worth $117M as of Q2 2026.
  • Pertento Partners bought 1,342,213 Cellebrite shares in Q2 2026, an estimated $17.7M.
  • Cellebrite made up 6.3% of Pertento Partners's portfolio in Q2 2026, its #6 holding.
  • Pertento Partners first reported a position in Cellebrite in Q3 2024 and has held it in 8 quarters since.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Pertento Partners's 13F filing for Q2 2026, filed 13 Aug 2026.